News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current VX1 market cap is 111.5B. The company's latest EPS is USD 13.8641 and P/E is 32.53.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.16B | 6.21B | 7.58B | 8.99B | 9.92B |
| Operating Income | 1.2B | 2.86B | 2.78B | 4.31B | 3.83B |
| Net Income | 1.18B | 2.71B | 2.34B | 3.32B | 3.57B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.32B | 11.75B | 13.43B | 18.15B | 22.73B |
| Total Liabilities | 2.23B | 3.06B | 3.33B | 4.24B | 5.15B |
| Total Equity | 6.09B | 8.69B | 10.1B | 13.91B | 17.58B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.57B | 3.25B | 2.64B | 4.13B | 3.54B |
| Investing | -1.24B | 99.39M | -340.9M | -321.1M | -3.14B |
| Financing | 126.77M | -505.28M | -1.48B | -67.7M | -562.2M |
| Market Cap | 111.5B |
| Price to Earnings Ratio | 32.53 |
| Price to Sales Ratio | 11.71 |
| Price to Cash Ratio | 11.2 |
| Price to Book Ratio | 6.61 |
| Dividend Yield | - |
| Shares Outstanding | 257.53M |
| Average Volume (1 week) | 628 |
| Average Volume (1 Month) | 676 |
| 52 Week Change | 32.56% |
| 52 Week High | 490.00 |
| 52 Week Low | 315.45 |
| Spread (Intraday) | 3.95 (0.91%) |
| Company Name | Vertex Pharmac Dl 01 |
| Address |
50 northern avenue boston, massachusetts 02210 |
| Website | https://www.vrtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
